Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reducing Circulating Sphingolipid Levels to Optimise Cardiometabolic Health - The SphingoFIT Randomised Controlled Exercise Trial

NCT06024291 is registered in ClinicalTrials.gov with University of Basel as lead sponsor.

NCT NCT06024291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06024291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reducing Circulating Sphingolipid Levels to Optimise Cardiometabolic Health - The SphingoFIT Randomised Controlled Exercise Trial
Lead sponsor
University of Basel
Phase
Not applicable
Overall status
Completed
Start date
September 15, 2023
Completion date
January 15, 2025
Enrollment
88 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure, cardiovascular diseases, dyslipidemias, metabolic disease, overweight and obesity